🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study was to determine whether treatment with a PI3K inh...
Status
Completed
Location
University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI
Start Date
2014-03-11
Trial ID
NCT01923168
Treatments Being Tested
This Phase III, randomized, double-blind, placebo-controlled, multicenter s...
Status
Active Not Recruiting
Location
Orange Coast Memorial Medical Center
Start Date
2020-10-09
Trial ID
NCT04546009
This is a two-arm, randomized, double-blind, multicenter, pre-operative stu...
Status
Completed
Location
Breastlink Med Group Inc
Start Date
2014-11-12
Trial ID
NCT02273973
This phase 3 clinical trial compares the efficacy and safety of palazestran...
Status
Recruiting
Location
Clinical Trial Site
Start Date
2025-11-03
Trial ID
NCT07085767
Treatments Being Tested
This study will evaluate the efficacy and safety of inavolisib in combinati...
Status
Recruiting
Location
Banner Health MD Anderson AZ
Start Date
2023-09-08
Trial ID
NCT05894239
This study aimed at evaluating the safety and efficacy of everolimus plus e...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-09-15
Trial ID
NCT03312738
Treatments Being Tested
There are no treatments specifically approved after recurrence or progressi...
Status
Completed
Location
Ironwood Cancer and Research Centers
Start Date
2009-06-03
Trial ID
NCT00863655
Treatments Being Tested
The primary purpose is to determine if high dose vitamin D3 reduces the inc...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2009-03
Trial ID
NCT00867217
Treatments Being Tested
Primary Objective: To determine whether Amcenestrant (SAR439859) in combin...
Status
Terminated
Location
Investigational Site Number :8400075
Start Date
2020-10-14
Trial ID
NCT04478266
This study evaluated and compared the efficacy and tolerability of lapatini...
Status
Completed
Location
Novartis Investigative Site
Start Date
2003-12-09
Trial ID
NCT00073528